Christopher G Goetz

Summary

Affiliation: Rush University Medical Center
Country: USA

Publications

  1. doi request reprint Charcot and Pasteur: intersecting orbits in fin de siècle French medicine
    Christopher G Goetz
    Rush University Medical Center, Chicago, IL 60612, USA
    J Hist Neurosci 18:378-86. 2009
  2. doi request reprint Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:2129-70. 2008
  3. ncbi request reprint Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS)
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 25:1190-4. 2010
  4. pmc Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations
    Jennifer G Goldman
    1 Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA
    Brain 137:849-59. 2014
  5. doi request reprint Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia
    Brandon Barton
    Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:248-53. 2012
  6. pmc Placebo influences on dyskinesia in Parkinson's disease
    Christopher G Goetz
    Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 23:700-7. 2008
  7. pmc Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Parkinsonism Relat Disord 19:806-11. 2013
  8. doi request reprint Which dyskinesia scale best detects treatment response?
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 28:341-6. 2013
  9. pmc Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Mov Disord 27:1129-36. 2012
  10. pmc Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
    Christopher G Goetz
    Movement Disorders Section, Department of Neurological Sciences, Rush University Medical Center, Suite 1106, Chicago, IL 60612, USA
    Neurology 75:1773-9. 2010

Detail Information

Publications69

  1. doi request reprint Charcot and Pasteur: intersecting orbits in fin de siècle French medicine
    Christopher G Goetz
    Rush University Medical Center, Chicago, IL 60612, USA
    J Hist Neurosci 18:378-86. 2009
    ..With different primary interests and different etiological views, side by side, they exemplified two models of French medicine at the close of the nineteenth century: medical scientist and scientific physician...
  2. doi request reprint Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:2129-70. 2008
    ..90 for each part), which support the use of sum scores for each part in preference to a total score of all parts. The combined clinimetric results of this study support the validity of the MDS-UPDRS for rating PD...
  3. ncbi request reprint Teaching program for the Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale: (MDS-UPDRS)
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 25:1190-4. 2010
    ..This training program is in English, but as non-English official translations of the MDS-UPDRS are developed, the program can be potentially modified into different languages...
  4. pmc Visuoperceptive region atrophy independent of cognitive status in patients with Parkinson's disease with hallucinations
    Jennifer G Goldman
    1 Rush University Medical Center, Department of Neurological Sciences, Chicago, IL, USA
    Brain 137:849-59. 2014
    ....
  5. doi request reprint Clinical validation of Movement Disorder Society-recommended diagnostic criteria for Parkinson's disease with dementia
    Brandon Barton
    Department of Neurological Sciences, Section of Parkinson Disease and Movement Disorders, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:248-53. 2012
    ..Revision of the checklist by altering or eliminating the 2 problematic checklist items may improve sensitivity...
  6. pmc Placebo influences on dyskinesia in Parkinson's disease
    Christopher G Goetz
    Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 23:700-7. 2008
    ..The magnitude and variance of placebo-related changes and the factors that influence them can be helpful in the design of future clinical trials of antidyskinetic agents...
  7. pmc Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Parkinsonism Relat Disord 19:806-11. 2013
    ..Thus, we examined the relationships among excessive daytime sleepiness, nighttime sleep quality and cognitive impairment in PD, including severity and specific cognitive deficits...
  8. doi request reprint Which dyskinesia scale best detects treatment response?
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 28:341-6. 2013
    ....
  9. pmc Clinical differences among mild cognitive impairment subtypes in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Mov Disord 27:1129-36. 2012
    ..Furthermore, increased burden of cognitive dysfunction, rather than type of cognitive deficit, may be associated with greater motor impairment in PD-MCI...
  10. pmc Hallucinations and sleep disorders in PD: ten-year prospective longitudinal study
    Christopher G Goetz
    Movement Disorders Section, Department of Neurological Sciences, Rush University Medical Center, Suite 1106, Chicago, IL 60612, USA
    Neurology 75:1773-9. 2010
    ..To assess prospectively progression and relationship of hallucinations and sleep disorders over a 10-year longitudinal study of patients with Parkinson disease (PD)...
  11. doi request reprint How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale
    Glenn T Stebbins
    Department of Neurological Sciences, Section of Movement Disorders, Rush University Medical Center, Chicago, IL 60612, USA
    Mov Disord 28:668-70. 2013
    ..With the advent of the MDS-UPDRS, a valid set of calculations for these phenotypes is needed...
  12. pmc Entorhinal cortex atrophy differentiates Parkinson's disease patients with and without dementia
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 27:727-34. 2012
    ..Thus, ERC atrophy on MRI may be a potential biomarker for dementia in PD, particularly in the setting of memory impairment...
  13. doi request reprint Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing device
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 24:551-6. 2009
    ....
  14. doi request reprint Visual plus nonvisual hallucinations in Parkinson's disease: development and evolution over 10 years
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 26:2196-200. 2011
    ..To capture the breadth and severity of hallucinations in chronically hallucinating patients with Parkinson's disease, screening inventories and practice-based interviews must include questions on both visual and nonvisual components...
  15. doi request reprint Temporal stability of the Unified Dyskinesia Rating Scale
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 26:2556-9. 2011
    ..The UDysRS has strong internal consistency and a reliable factor structure, but the important issue of temporal stability has not been established...
  16. doi request reprint Placebo response in Parkinson's disease: comparisons among 11 trials covering medical and surgical interventions
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:690-9. 2008
    ..Recognition of factors that impact placebo response rates should be incorporated into individual study designs for PD clinical trials...
  17. ncbi request reprint Age-related influences on the clinical characteristics of new-onset hallucinations in Parkinson's disease patients
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 21:267-70. 2006
    ..Age-related disinhibition may facilitate wider cortical activation in PD and potentiate aberrant signaling that invokes other types of hallucinations besides the classic visual forms...
  18. ncbi request reprint Teaching program for the Unified Dyskinesia Rating Scale
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 24:1296-8. 2009
    ..Large-scale multicenter randomized clinical trials of dyskinesia treatment are strengthened by a uniform standard of scale application...
  19. doi request reprint Calibration of unified Parkinson's disease rating scale scores to Movement Disorder Society-unified Parkinson's disease rating scale scores
    Christopher G Goetz
    Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 27:1239-42. 2012
    ..Because Part I collects data on much more extensive information than the UPDRS, and because Part IV is structured differently in the two versions, old ratings for these parts cannot be converted. © 2012 Movement Disorder Society...
  20. ncbi request reprint Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Process, format, and clinimetric testing plan
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 22:41-7. 2007
    ....
  21. doi request reprint Evaluating Parkinson's disease patients at home: utility of self-videotaping for objective motor, dyskinesia, and ON-OFF assessments
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:1479-82. 2008
    ..In this group of patients with no or mild fluctuations, in spite of pretrial training, patients were inaccurate in separating ON vs. OFF status...
  22. doi request reprint Antipsychotic medication treatment for mild hallucinations in Parkinson's disease: Positive impact on long-term worsening
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:1541-5. 2008
    ....
  23. doi request reprint The Unified Dyskinesia Rating Scale: presentation and clinimetric profile
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 23:2398-403. 2008
    ..The UDysRS is a clinimetrically sound rating scale for dyskinesia in PD, demonstrating acceptable levels of internal consistency and inter- and intra-rater reliability. Testing scale responsivity to treatment interventions is planned...
  24. ncbi request reprint Evidence-based medical review update: pharmacological and surgical treatments of Parkinson's disease: 2001 to 2004
    Christopher G Goetz
    Department of Neurological Sciences, Department of Pharmacology, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 20:523-39. 2005
    ..We consider a 3-year period a reasonable time frame for published updates and are working to establish a Web-based mechanism to update the report in an ongoing manner...
  25. ncbi request reprint Vibration therapy for Parkinson's disease: Charcot's studies revisited
    Sachin S Kapur
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    J Parkinsons Dis 2:23-7. 2012
    ..However, there was no significant difference between the two treatment groups, suggesting that non-specific or placebo factors had an effect on PD motor function...
  26. ncbi request reprint The malignant course of "benign hallucinations" in Parkinson disease
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, 1725 W Harrison Street, Chicago, IL 60612, USA
    Arch Neurol 63:713-6. 2006
    ..To monitor progression of "benign hallucinations" in Parkinson disease (PD)...
  27. ncbi request reprint Does seasonal variation affect hallucinations in PD? A longitudinal study
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 21:863-5. 2006
    ..Because we found no evidence of seasonal variations, we cannot recommend phototherapy or other strategies affecting chronobiological systems as research priorities to treat PD hallucinations. (c) 2006 Movement Disorder Society...
  28. pmc Shaking up the Salpetriere: Jean-Martin Charcot and mercury-induced tremor
    Christopher G Goetz
    Rush University Medical Center, Chicago, IL 60612, USA
    Neurology 74:1739-42. 2010
    ..To analyze Jean-Martin Charcot's studies of mercury-induced tremor...
  29. doi request reprint Determinants of quality of life in children with Gilles de la Tourette syndrome
    Bryan A Bernard
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 24:1070-3. 2009
    ..ADHD with predominantly inattentive symptoms, rather than hyperactivity symptoms, was associated with lower QOL. To improve QOL, clinicians must consider treatments of co-morbidities among tic patients...
  30. ncbi request reprint J.-M. Charcot and simulated neurologic disease: attitudes and diagnostic strategies
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL 60612, USA
    Neurology 69:103-9. 2007
    ..Neurologists have long wrestled with the diagnosis of elaborated or feigned disease. Studies have not focused on early techniques utilized to diagnose malingering...
  31. doi request reprint Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 28:1972-9. 2013
    ..The predominance of multiple domain impairment in PD-MCI with the Level II criteria suggests not only influences of testing abnormality requirements, but also the widespread nature of cognitive deficits within PD-MCI...
  32. pmc The history of Parkinson's disease: early clinical descriptions and neurological therapies
    Christopher G Goetz
    Department of Neurological Sciences and Department of Pharmacology, Rush University Medical Center, Chicago, Illinois 60612, USA
    Cold Spring Harb Perspect Med 1:a008862. 2011
    ....
  33. doi request reprint Effects of dopaminergic medications on psychosis and motor function in dementia with Lewy bodies
    Jennifer G Goldman
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 23:2248-50. 2008
    ..Our results suggest that dopaminergic medications have limited benefit in DLB because of the low likelihood of motor improvement and the risk of psychosis exacerbation...
  34. pmc An update expert opinion on management and research strategies in Parkinson's disease psychosis
    Jennifer G Goldman
    Rush University Medical Center, Department of Neurological Sciences, 1725 W Harrison Street, Chicago, IL 60612, USA
    Expert Opin Pharmacother 12:2009-24. 2011
    ..Safe, effective treatments that improve psychosis without exacerbating parkinsonism are urgently needed...
  35. doi request reprint Scales to evaluate psychosis in Parkinson's disease
    Christopher G Goetz
    Rush University Medical Center, Chicago, IL 60612, USA
    Parkinsonism Relat Disord 15:S38-41. 2009
    ..The Task Force officially recommended the development of a new scale to assess hallucinations and psychosis in Parkinson's disease. This effort is now ongoing with official endorsement by the Movement Disorder Society...
  36. doi request reprint Association between antipsychotics and body mass index when treating patients with tics
    Katie Kompoliti
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illionois 60612, USA
    J Child Adolesc Psychopharmacol 20:277-81. 2010
    ..The objective of this study is to investigate the relationship between antipsychotic use and weight in tic patients and compare the effects of SGAs to first-generation (typical) antipsychotics (FGAs)...
  37. doi request reprint Jean-Martin Charcot and his vibratory chair for Parkinson disease
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
    Neurology 73:475-8. 2009
    ..Although after Charcot's death vibratory therapy was not widely pursued, vibratory appliances are reemerging in 21st century medicine and can be retested using adaptations of Charcot's neurologic protocols...
  38. ncbi request reprint Sarizotan as a treatment for dyskinesias in Parkinson's disease: a double-blind placebo-controlled trial
    Christopher G Goetz
    Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 22:179-86. 2007
    ..Sarizotan 2 mg/day is a safe agent in PD patients with dyskinesia. To test its role in abating dyskinesia, future studies should focus on this dose and will use the composite score of UPDRS Items 32+33 as the primary outcome...
  39. ncbi request reprint Progression of gait, speech and swallowing deficits in progressive supranuclear palsy
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Center, Chicago, IL, USA
    Neurology 60:917-22. 2003
    ..To identify outcome measures for clinical trials in progressive supranuclear palsy (PSP), the authors determined the time to key motor impairments in a well-defined patient cohort...
  40. ncbi request reprint Tremor and ataxia in fragile X premutation carriers: blinded videotape study
    Elizabeth Berry-Kravis
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
    Ann Neurol 53:616-23. 2003
    ..Given the relatively high population frequency of the FMR1 premutation, this mutation may be a significant cause of late-onset "idiopathic" progressive tremor...
  41. ncbi request reprint Impact of placebo assignment in clinical trials of Parkinson's disease
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 18:1146-9. 2003
    ..Although most wish they received the active compound being tested, the overall view of participation in placebo-controlled trials is viewed very positively by PD patients...
  42. ncbi request reprint Jean-Martin Charcot and the aging brain
    Christopher G Goetz
    Department of Neurological Sciences and Pharmacology, Rush University Rush Presbyterian St Luke s Medical Center, 1725 W Harrison St, Chicago, IL 60612, USA
    Arch Neurol 59:1821-4. 2002
  43. ncbi request reprint The election of Sarah McNutt as the first woman member of the American Neurological Association
    Stacy S Horn
    Department of Neurological Sciences, Rush University, Chicago, IL 60612, USA
    Neurology 59:113-7. 2002
    ..Her historic election acknowledged her accomplishments and highlighted the proactive role of the early ANA in forging new medical policies in the United States...
  44. ncbi request reprint Standardized training tools for the UPDRS activities of daily living scale: newly available teaching program
    Christopher G Goetz
    Department of Neurological Sciences, Rush University, Rush Presbyterian St Luke s Medical Center, Chicago, Illinois, USA
    Mov Disord 18:1455-8. 2003
    ..The written materials and videotape belong to the Movement Disorder Society and are available by contacting the MDS central office...
  45. ncbi request reprint Placebo-associated improvements in motor function: comparison of subjective and objective sections of the UPDRS in early Parkinson's disease
    Christopher G Goetz
    Department of Neurological Sciences Rush University, Rush Presbyterian St Luke s Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 17:283-8. 2002
    ....
  46. ncbi request reprint History of the extensor plantar response: Babinski and Chaddock signs
    Christopher G Goetz
    Rush Medical College, Chicago, Illinois, USA
    Semin Neurol 22:391-8. 2002
    ....
  47. doi request reprint I finally see what you see: Parkinson's disease visual hallucinations captured with functional neuroimaging
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 29:115-7. 2014
    ..The objective of this work was to investigate neuroanatomical substrates active during visual hallucinations in a patient with Parkinson's disease (PD)...
  48. ncbi request reprint Medical-legal issues in Charcot's neurologic career
    Christopher G Goetz
    Rush University Medical Center, Chicago, IL 60612, USA
    Neurology 62:1827-33. 2004
    ..Trace the medical-legal involvement of the 19th century clinical neurologist Jean-Martin Charcot...
  49. pmc Treating melancholia at home: theoretical wisdom and grim reality in the career of E.C. Seguin
    Christopher G Goetz
    Rush University Medical Center, Chicago, IL, USA
    Neurology 80:1710-4. 2013
    ..The grim dichotomy between the confidently written paper and the reality of the treatment failure is a neurologic lesson in humility regarding diseases and their unpredictable outcomes...
  50. ncbi request reprint Pierre Marie: gifted intellect, poor timing and unchecked emotionality
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Centre, 1725 W Harrison Street, Suite 755, Chicago, IL 60612, USA
    J Hist Neurosci 12:154-66. 2003
    ..In the context of his time, these elements prompted Marie to enter into controversies and medico-political battles that advanced neurological knowledge, but likely disadvantaged him in his career successes...
  51. ncbi request reprint Charcot in contemporary literature
    Christopher G Goetz
    Neurological Sciences and Pharmacology, Rush University Medical Center, IL 60612, USA
    J Hist Neurosci 15:22-30. 2006
    ..Neurologists should not look to these works as replacements for more seriously composed historical studies, but as enrichments anchored in the imaginative possibilities of Charcot and his fin de siècle era...
  52. ncbi request reprint Assuring interrater reliability for the UPDRS motor section: utility of the UPDRS teaching tape
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 19:1453-6. 2004
    ..Raters have the greatest difficulty with the mildest impairment, making training especially important to studies of early PD...
  53. doi request reprint Chapter 15: Jean-Martin Charcot and the anatomo-clinical method of neurology
    Christopher G Goetz
    Department of Neurological Sciences and Pharmacology, Rush University Medical Center, Chicago, IL 60612, USA
    Handb Clin Neurol 95:203-12. 2010
    ..In the context of Charcot's extensive discoveries and lasting contributions, the anatomo-clinical method remains the anchor of modern neurological diagnosis and is Charcot's most important contribution to clinical neurology...
  54. doi request reprint Parkinson's disease dementia: definitions, guidelines, and research perspectives in diagnosis
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, IL, USA
    Ann Neurol 64:S81-92. 2008
    ..The inclusion criteria can be applied internationally and in multicenter research on treatment interventions, clinicopathological correlations, and studies of cognitive and other nonmotor elements of PD...
  55. ncbi request reprint Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations
    Christopher G Goetz
    Rush University Medical Center, 1725 W Harrison Street, Chicago, IL 60612, USA
    Mov Disord 19:1020-8. 2004
    ..5 increments, this adaptation warrants clinimetric testing. Without such testing, however, the original five-point scales should be maintained...
  56. ncbi request reprint Neuropathic features in fragile X premutation carriers
    Elizabeth Berry-Kravis
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Am J Med Genet A 143:19-26. 2007
    ..These data suggest that neuropathic signs are associated with the fragile X premutation, presumably occurring through the same mechanism proposed for CNS disease, namely, toxicity from expanded-CGG-repeat FMR1 mRNA...
  57. ncbi request reprint Fragile X-associated tremor/ataxia syndrome in sisters related to X-inactivation
    Elizabeth Berry-Kravis
    Department of Pediatrics, Rush University Medical Center, 1275 West Harrison Street, Suite 718, Chicago, IL 60612, USA
    Ann Neurol 57:144-7. 2005
    ....
  58. doi request reprint New developments in depression, anxiety, compulsiveness, and hallucinations in Parkinson's disease
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 25:S104-9. 2010
    ..New treatments are being developed, but there have been very few large-scale randomized clinical trials to test the relative roles of new or available agents for abating these problematic behaviors...
  59. ncbi request reprint Movement disorders: understanding clinical trials
    Christopher G Goetz
    Rush University Medical Center, Chicago IL 60612, USA
    Lancet Neurol 4:5-6. 2005
  60. ncbi request reprint Treatment of advanced Parkinson's disease: an evidence-based analysis
    Christopher G Goetz
    Department of Neurological Sciences, Department of Pharmacology, Rush University Rush Presbyterian St Luke s Medical Center, Chicago, Illinois, USA
    Adv Neurol 91:213-28. 2003
  61. pmc Are patients with Parkinson's disease blind to blindsight?
    Nico J Diederich
    1 Department of Neurosciences, Centre Hospitalier de Luxembourg, Luxembourg City, Luxembourg2 Centre for Systems Biomedicine, University of Luxembourg, Esch Belval, Luxembourg3 Department of Neurological Sciences, Rush University Medical Centre, Chicago, USA
    Brain 137:1838-49. 2014
    ....
  62. ncbi request reprint Hallucinations and sleep disorders in PD: six-year prospective longitudinal study
    Christopher G Goetz
    Department of Neurological Sciences, Rush Medical College, Rush University, Chicago, IL, USA
    Neurology 64:81-6. 2005
    ..To prospectively assess the relationship of hallucinations to sleep disorders in patients with Parkinson disease (PD) over 6 years...
  63. doi request reprint Movement disorders caused by medical disease
    Brandon Barton
    Department of Neurological Sciences, Movement Disorders Section, Rush University Medical Center, Chicago, Illinois 60612, USA
    Semin Neurol 29:97-110. 2009
    ..The spectrum of medical diseases associated with these four syndromes is reviewed in this article...
  64. ncbi request reprint Genetic polymorphisms in Parkinson disease subjects with and without hallucinations: an analysis of the cholecystokinin system
    Jennifer G Goldman
    Department of Neurological Sciences, Rush Presbyterian St Luke s Medical Center, Chicago, Ill 60612, USA
    Arch Neurol 61:1280-4. 2004
    ..Because CCK gene polymorphisms vary across ethnic groups, the presence of similar associations in white PD subjects merits investigation...
  65. ncbi request reprint Gilles de la Tourette syndrome: patient's knowledge and concern of adverse effects
    Katie Kompoliti
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 21:248-52. 2006
    ..Overall, patient awareness of NL side effects is insufficient, and although past exposure to NLs enhances knowledge, it decreases concern...
  66. ncbi request reprint The prefaces by Charcot: leitmotifs of an international career
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Rush Presbyterian St Luke s Medical Center, Chicago, IL 60612, USA
    Neurology 60:1333-40. 2003
    ....
  67. doi request reprint Comparison of tic characteristics between children and adults
    Esther Cubo
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois, USA
    Mov Disord 23:2407-11. 2008
    ..004) when compared with adults. Tic phenomenology and severity were similar between children and adults, but pharmacological tic management was different, perhaps reflecting a practice trend to avoid medications in children...
  68. ncbi request reprint Early cinematographic studies of generalized dystonia
    Christopher G Goetz
    Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 21:1561-5. 2006
    ..The films demonstrate the variety of dystonic movements appreciated during this period, consider psychogenic, postencephalitic, and hereditary forms, and refer to the treatment of dystonia by surgery and plaster casts...
  69. doi request reprint The movement disorder society and movement disorders: a modern history
    Christopher G Goetz
    Rush University Medical Center, Chicago, Illinois 60612, USA
    Mov Disord 26:939-46. 2011
    ..Movement Disorders has a continuingly growing subscribership and rising impact factor...